Authors: KOUVIDOU C STEFANAKI K DAI Y TZARDI M KOUTSOUBI K DARIVIANAKI K KARIDI E RONTOGIANNI D ZOIS E KAKOLYRIS S GEORGOULIAS V DELIDES G KANAVAROS P

Citation: C. Kouvidou et al., P21 WAF1 PROTEIN EXPRESSION IN NASOPHARYNGEAL CARCINOMA - COMPARATIVE-STUDY WITH PCNA, P53 AND MDM-2 PROTEIN EXPRESSION/, Anticancer research, 17(4A), 1997, pp. 2615-2619

Authors: GIANNIKAKI E KOUVIDOU C TZARDI M STEFANAKI K KOUTSOUBI K GREGORIOU M ZOIS E KAKOLYRIS S MAVROUDI C DELIDES G GREGORIOU M GEORGOULIAS V KANAVAROS P

Citation: E. Giannikaki et al., P53 PROTEIN EXPRESSION IN BREAST CARCINOMAS - COMPARATIVE-STUDY WITH THE WILD-TYPE P53 INDUCED PROTEINS MDM2 AND P21 WAF1/, Anticancer research, 17(3C), 1997, pp. 2123-2127

Authors: KALOGERAKI A TZARDI M PANAGIOTIDES I KOUTSOUBI K BOLIOTI S RONTOGIANNI D STEFANAKI K ZOIS E KARIDI E DARIVIANAKI K DELIDES G KANAVAROS P

Citation: A. Kalogeraki et al., MIB1 (KI-67) EXPRESSION IN NON-HODGKINS-LYMPHOMAS, Anticancer research, 17(1A), 1997, pp. 487-491

Authors: TZARDI M KOUVIDOU C PANAYIOTIDES I STEFANAKI K RONTOGIANNI D ZOIS E KOUTSOUBI K ELIOPOULOS G DELIDES G KANAVAROS P

Citation: M. Tzardi et al., P53 PROTEIN EXPRESSION IN NON-HODGKINS-LYMPHOMA - COMPARATIVE-STUDY WITH THE WILD-TYPE P53 INDUCED PROTEINS MDM2 AND P21 WAF1/, JCP. Clinical molecular pathology, 49(5), 1996, pp. 278-282

Authors: TZARDI M KOUVIDOU C PANAYIOTIDES I KOUTSOUBI K STEFANAKI K GIANNIKAKI E DARIVIANAKI K ZOIS M ELIOPOULOS G KAKOLYRIS S DELIDES G RONTOGIANNI D KANAVAROS P

Citation: M. Tzardi et al., EXPRESSION OF P53 AND MDM-2 PROTEINS IN HODGKINS-DISEASE - ABSENCE OFCORRELATION WITH THE PRESENCE OF EPSTEIN-BARR-VIRUS, Anticancer research, 16(5A), 1996, pp. 2813-2819